Umbilical cord blood and maternal visfatin (PBEF/NAMPT) concentrations in preterm birth with and without preterm premature rupture of membranes

References

• Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10:S2.
   PubMed Web of Science ®Google Scholar
• Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med. 2012;17:12–19.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Medina TM, Hill DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Phys. 2006;73:659–664.
   PubMed Web of Science ®Google Scholar
• Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1:11–22.
   PubMedGoogle Scholar
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430.
   PubMed Web of Science ®Google Scholar
• Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431–1437.
   PubMed Web of Science ®Google Scholar
• Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002;32:3225–3234.
   PubMed Web of Science ®Google Scholar
• Garten A, Schuster S, Penke M, et al. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 2015;11:535–546.
   PubMed Web of Science ®Google Scholar
• HuangWei J, Lu EY. Research advances on the roles of nicotinamide phosphoribosyltransferase in inflammation. Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci. 2014;43:234–239.
   PubMedGoogle Scholar
• Rongvaux A, Andris F, Van Gool F, et al. Reconstructing eukaryotic NAD metabolism. Bioessays. 2003;25:683–690.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Valsamakis G, Papatheodorou DC, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007;53:1477–1483.
   PubMed Web of Science ®Google Scholar
• Morgan SA, Bringolf JB, Seidel ER. Visfatin expression is elevated in normal human pregnancy. Peptides. 2008;29:1382–1389.
   PubMed Web of Science ®Google Scholar
• Mazaki-Tovi S, Romero R, Kusanovic JP, et al. Maternal visfatin concentration in normal pregnancy. J Perinat Med. 2009;37:206–217.
   PubMed Web of Science ®Google Scholar
• Szamatowicz Kuźmicki J, Telejko M, Zonenberg B, et al. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes. Ginekol Pol. 2009;80:14–18.
   PubMed Web of Science ®Google Scholar
• Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051–1058.
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana DD, Gourgiotis D, et al. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr Oslo Paediatr. 2007;96:526–529.
   PubMed Web of Science ®Google Scholar
• Kendal-Wright CE, Hubbard D, Bryant-Greenwood GD. Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor (PBEF/visfatin) expression and protects them from apoptosis. Placenta. 2008;29:255–265.
   PubMed Web of Science ®Google Scholar
• Kendal-Wright CE, Hubbard D, Gowin-Brown J, et al. Stretch and inflammation-induced Pre-B cell colony-enhancing factor (PBEF/Visfatin) and Interleukin-8 in amniotic epithelial cells. Placenta. 2010;31:665–674.
   PubMed Web of Science ®Google Scholar
• Marvin KW, Keelan JA, Eykholt RL, et al. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod. 2002;8:399–408.
   PubMed Web of Science ®Google Scholar
• Ognjanovic S, Tashima LS, Bryant-Greenwood GD. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol. 2003;189:1187–1195.
   PubMed Web of Science ®Google Scholar
• Mumtaz S, AlSaif S, Wray S, et al. Inhibitory effect of visfatin and leptin on human and rat myometrial contractility. Life Sci. 2015;125:57–62.
   PubMed Web of Science ®Google Scholar
• Goffinet F. Primary predictors of preterm labour. BJOG. 2005;112 Suppl 1:38–47.
   PubMed Web of Science ®Google Scholar
• Untergasser A, Cutcutache I, Koressaar T, et al. Primer3-new capabilities and interfaces. Nucleic Acids Res. 2012;40:e115.
   PubMed Web of Science ®Google Scholar
• Tokunaga A, Miura A, Okauchi Y, et al. The –1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects. Endocr J. 2008;55:205–212.
   PubMed Web of Science ®Google Scholar
• Stastny J, Bienertova-Vasku J, Tomandl J, et al. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population. Diabetes Metab Syndr. 2013;7:166–171.
   PubMedGoogle Scholar
• Pavlová T, Novák J, Bienertová-Vašků J. The role of visfatin (PBEF/Nampt) in pregnancy complications. J Reprod Immunol. 2015;112:102–110.
   PubMed Web of Science ®Google Scholar
• Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Maternal plasma visfatin in preterm labor. J Matern-Fetal Neonatal Med. 2009;22:693–704.
   PubMed Web of Science ®Google Scholar
• Bienertová-Vašků J, Bienert P, Zlámal F, et al. Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth. Diabetes Res Clin Pract. 2012;96:355–361.
   PubMed Web of Science ®Google Scholar
• Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term. J Perinat Med. 2010;38:281–288.
   PubMed Web of Science ®Google Scholar
• López-Bermejo A, De Zegher F, Díaz-Silva M, et al. Cord serum visfatin at term birth: maternal smoking unmasks the relation to foetal growth. Clin Endocrinol (Oxf). 2008;68:77–81.
   PubMed Web of Science ®Google Scholar
• CekmezPirgon F, Tanju OA, Ipcioglu OM. Cord plasma concentrations of visfatin, adiponectin and insulin in healthy term neonates: positive correlation with birthweight. Int J Biomed Sci IJBS. 2009;5:257–260.
   PubMedGoogle Scholar
• Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics. 2007;119:e1314–e1318.
   PubMed Web of Science ®Google Scholar
• Oncul M, Tuten A, Erman H, et al. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus. Minerva Med. 2013;104:527–535.
   PubMed Web of Science ®Google Scholar
• Valsamakis G, Papatheodorou D, Margeli C, et al. First trimester maternal BMI is a positive predictor of cord blood c-peptide levels while maternal visfatin levels is a negative predictor of birth weight. Hormones (Athens Greece). 2014;13:87–94.
   PubMedGoogle Scholar
• Mazaki-Tovi S, Vaisbuch E, Romero R, et al. Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestationalage neonate. J Matern-Fetal Neonatal Med. 2010;23:1119–1128.
   PubMed Web of Science ®Google Scholar